Lifeboat Foundation

We look at the latest in regenerative medicine for treating knee problems. Osteoarthritis happens when the meniscus and cartilage wear out. Researchers aim to repair meniscal damage with autologous synovial stem cell transplants. Ligament tears, an injury common among athletes, are also usually treated with transplants using the patient’s own tendons or artificial ligaments. A bovine tendon has successfully been transplanted into a sheep, and a clinical trial will soon begin for use in humans.

Brian Cummings, UCI professor of physical medicine & rehabilitation and founding member of the Sue & Bill Gross Stem Cell Research Center, has received a five-year, $2.7 million grant from the California Institute for Regenerative Medicine to establish a training program that supports first-generation and underserved students pursuing careers in public health and regenerative medicine. The Creating Opportunities Through Mentorship and Partnership Across Stem Cell Science program will pair student scholars with faculty mentors. With their tuition covered and a stipend provided during their two years as scholars, the students will learn hands-on lab skills and human cell culture; be introduced to good manufacturing procedures in UCI’s new GMP facility; and earn a certificate in clinical research coordination. “COMPASS provides the opportunity for students to explore a variety of ways in which their education and research skills can be applied toward improving human health through career paths in the public and private sectors. UCI’s COMPASS scholars program will produce a cadre of well-trained individuals who are ready to contribute to the workforce,” said Cummings, who is also the School of Medicine’s associate dean for faculty development. “A parallel objective is to foster greater awareness and appreciation of diversity, equity and inclusion in trainees, mentors and other program participants.” Administered via the Sue & Bill Gross Stem Cell Research Center, the program will train 25 undergraduate and two-year college transfer students.

Increasing studies have reported the therapeutic effect of mesenchymal stem cell (MSC)-derived exosomes by which protein and miRNA are clearly characterized. However, the proteomics and miRNA profiles of exosomes derived from human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs) remain unclear.

In this study, we isolated exosomes from hESCs, hiPSCs, and human umbilical cord mesenchymal stem cells (hUC-MSCs) via classic ultracentrifugation and a 0.22-μm filter, followed by the conservative identification. Tandem mass tag labeling and label-free relative peptide quantification together defined their proteomics. High-throughput sequencing was performed to determine miRNA profiles. Then, we conducted a bioinformatics analysis to identify the dominant biological processes and pathways modulated by exosome cargos. Finally, the western blot and RT-qPCR were performed to detect the actual loads of proteins and miRNAs in three types of exosomes.

Based on our study, the cargos from three types of exosomes contribute to sophisticated biological processes. In comparison, hESC exosomes (hESC-Exos) were superior in regulating development, metabolism, and anti-aging, and hiPSC exosomes (hiPSC-Exos) had similar biological functions as hESC-Exos, whereas hUC-MSCs exosomes (hUC-MSC-Exos) contributed more to immune regulation.

Dr Brian Kennedy on Rejuvant, human longevity trials, aging optimally and why individual response to intervention is key.

Alpha-ketoglutarate (AKG) is used by cells during growth and in healing from injuries; studies have shown it may be effective in treating osteoporosis, preventing a decline in protein synthesis, reducing frailty and, in some mammalian studies; even extending lifespan. has gone one step further, adding calcium to produce LifeAKG™, a patent-pending, highly bioavailable and ultra pure CaAKG supplement, backed by extensive research and double-blind placebo-controlled clinical trials.

Continue reading “Human longevity trials and aging with Dr Brian Kennedy” »

New Kurzweil Vid!, September 17, 2022!

Ray Kurzweil is an author, inventor, and futurist. Please support this podcast by checking out our sponsors:
- Shopify: https://shopify.com/lex to get 14-day free trial.
- NetSuite: http://netsuite.com/lex to get free product tour.
- Linode: https://linode.com/lex to get $100 free credit.
- MasterClass: https://masterclass.com/lex to get 15% off.
- Indeed: https://indeed.com/lex to get $75 credit.

Continue reading “Ray Kurzweil: Singularity, Superintelligence, and Immortality | Lex Fridman Podcast #321” »

Circa 2008 face_with_colon_three

Adult bone marrow (BM) houses a tiny pool of hematopoietic stem cells (HSCs) that have the ability to maintain not only themselves but also all the rest of highly turning over blood lineages throughout the mammalian life (1, 2). Hence, the ability to sustain HSC in tissue culture would allow serial introduction of gain or loss of function mutations efficiently in hematopoietic system. However, our failure to expand HSC in culture has hampered the use of this approach. In fact, BM suspension cultures lose rapidly their HSC content despite vigorous growth of progenitors and more differentiated cells at least for 3 weeks even in optimal cytokine milieu (3, 4). Therefore, the phenomenon of stem cell exhaustion or senescence may set the limits that make it impossible even in principle to expand HSC in culture for longer periods (5–7).

Mouse HSC do expand in vivo (8, 9), at least up to 8000-fold, as shown by Iscove and Nawa (9) through serial transplantation experiments that assessed carefully the input and output contents of HSC in each transfer generation. Recently also in vitro approaches have been improved and refined culture conditions with new growth factors can now support up to 30-fold expansion of mouse HSC ex vivo (10). However, since it is not clear to what extent external culture conditions can be improved, alternative but not mutually exclusive efforts to change the intrinsic properties of HSC have been taken. Seminal experiments in this respect by Humphries, Savageau and their colleagues have shown that ectopic expression of HOXB4 transcription factor in BM cells support the survival and expansion of HSC in vivo and importantly also in vitro (11–13). By rigorously monitoring the HSC content in their cultures of HOXB4-transduced BM cells, they found that HSC could be expanded up to 41-fold in the 2-week liquid cultures (13). HOXB4 belongs to a large family of HOX transcription factors that are crucial for the basic developmental processes in addition to their role in maintenance of different stem cell compartments.

Continue reading “Manipulation of immune system via immortal bone marrow stem cells” »

A study on naked mole rats could help scientists prevent and better treat human illnesses.

According to new research conducted by University of Cambridge scientists, naked mole rats age healthily, very rarely get cancer, and are numb to acid.

The team hopes to utilize these insights to find better treatment methods for human illnesses and inflammatory conditions such as arthritis, according to an institutional press release.

With billions of dollars flooding into longevity, what role will epigenetic clocks play in measuring and intervening in aging?

When Horvath first described epigenetic clocks, scientists began to speculate that altering them could reverse aging. After all, if certain patterns of DNA methylation at certain sites in cells in certain tissues of your body are hallmarks of aging, could shifting them somehow reverse aging?

Looking at DNA in a tissue sample is now all you need to accurately work out the age of almost any mammal, and this reveals something fundamental about ageing.